Mining Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mining Press Releases.

Press releases published on October 2, 2026

Oct. 2, 2026

pMD® Completes Annual SOC 2® Type II and HIPAA Security Audits

Indeterminate GlobeNewswire

Oct. 2, 2026

Pasqal Appoints Roger L. Chuchen as Head of Investor Relations

Indeterminate GlobeNewswire

Oct. 2, 2026

WISeQey’s Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation

Indeterminate GlobeNewswire

Oct. 2, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares

Indeterminate GlobeNewswire

Oct. 2, 2026

Covenant Logistics Group, Inc. Announces Timing of Third Quarter Earnings Release and Conference Call

Indeterminate GlobeNewswire

Oct. 2, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Oct. 2, 2026

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

SEALSQ’s Sister Company, WISeSat.Space, Completes Business Combination with Columbus Acquisition Corporation

Indeterminate GlobeNewswire

Oct. 2, 2026

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 2, 2026

Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System

Indeterminate GlobeNewswire

Oct. 2, 2026

Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire